Patent Assignment
Reel/Frame 021336/0565
Assignment of Assignor's Interest
Recorded: 2008-08-04
Pages: 9
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2008-07-17
Assignee
GENZYME CORPORATION
500 KENDALL STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(21)
Antisense Modulation of Apolipoprotein B Expression
PCT:
PCT/US2002/024247 ↗
Antisnese Modulation of Apolipoprotein B Expression
PCT:
PCT/US2003/015493 ↗
Antisense Modulation of Apolipoprotein B Expression
PCT:
PCT/US2003/036411 ↗
Methods for Modulating Lipoprotein and Cholesterol Levels in Humans
PCT:
PCT/US2005/028342 ↗
Administering Oligonucleotides
PCT:
PCT/US2008/058072 ↗
Antisense Modulation of Apolipoprotein B Expression
Antisense modulation of apolipoprotein B expression
Application:
10/135,985 →
Antisense Modulation of Apolipoprotein B Expression
Antisense Modulation of Apolipoprotein B Expression
Antisense Modulation of Apolipoprotein B-Expression
Effects of apolipoprotein B inhibition on gene expression profiles in animals
Application:
11/123,656 →
Publication:
US 2006/0009410
SNPs of apolipoprotein B and modulation of their expression
Application:
11/124,020 →
Publication:
US 2005/0287558
Methods for modulating lipoprotein and cholesterol levels in humans
Application:
11/200,710 →
Publication:
US 2006/0035858
Antisense Modulation of Apolipoprotein B Expression
Application:
11/573,537 →
Publication:
US 2009/0326040
Antisense Modulation of Apolipoprotein B Expression
Inhibition of ApoB-100 for the treatment of hyperlipidemias
Application:
60/426,234 →
SNPS of apolipoprotein B and modulation of their expression
Application:
60/568,409 →
Effects of apolipoprotein B inhibition on gene expression profiles in animals
Application:
60/568,825 →
Methods for modulating lipoprotein and cholesterol levels in humans
Application:
60/600,785 →
Methods for modulating lipoprotein and cholesterol levels in humans
Application:
60/612,831 →
Administering Oligonucleotides
Application:
60/896,914 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 4, 2002
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012595/0014 →
Assignment of Assignor's Interest
Aug 6, 2002
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 013168/0255 →
Assignment of Assignor's Interest
May 27, 2003
From: GRAHAM, MARK J.; MARTURANO, BEATRICE; LEMONIDIS, KRISTINA M.; CROOKE, ROSANNE M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 014095/0398 →
Assignment of Assignor's Interest
Jun 21, 2004
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.; TARBET, KRISTINA L.; DOBIE, KENNETH W.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 015476/0813 →
Assignment of Assignor's Interest
Mar 2, 2005
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 015820/0735 →
Assignment of Assignor's Interest
Mar 3, 2005
From: CROOKE, ROSANNE M.; GRAHAM, MARK
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 015825/0802 →
Assignment of Assignor's Interest
Mar 3, 2005
From: MAH, STEVEN
To: SEQUENOM, INC.
Reel/Frame 015825/0781 →
Assignment of Assignor's Interest
May 16, 2005
From: GEARY, RICHARD S.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016218/0613 →
Assignment of Assignor's Interest
Jun 29, 2005
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016440/0833 →
Assignment of Assignor's Interest
Jul 15, 2005
From: GEARY, RICHARD S.; YU, ZHENGRONG
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016538/0464 →
Assignment of Assignor's Interest
Aug 19, 2005
From: MAH, STEVEN
To: SEQUENOM, INC.
Reel/Frame 016652/0958 →
Assignment of Assignor's Interest
Aug 19, 2005
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016652/0754 →
Assignment of Assignor's Interest
Oct 20, 2005
From: GEARY, RICHARD S.; CROOKE, ROSANNE M.; YU, ZHENGRONG
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016917/0838 →
Assignment of Assignor's Interest
Nov 2, 2005
From: FREIER, SUSAN M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016972/0189 →
Assignment of Assignor's Interest
Nov 3, 2005
From: FREIER, SUSAN M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 016978/0850 →
Assignment of Assignor's Interest
Apr 26, 2007
From: GEARY, RICHARD S.; YU, ZHENGRONG
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 019218/0564 →
Assignment of Assignor's Interest
Jan 25, 2008
From: GEARY, RICHARD S.; YU, ZHENGRONG; CROOKE, ROSANNE M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 020418/0581 →
Assignment of Assignor's Interest
Jul 28, 2008
From: ISIS PHARMACEUTICALS, INC.
To: GENZYME CORPORATION
Reel/Frame 021303/0099 →
Assignment of Assignor's Interest
Jul 29, 2010
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.; CROOKE, ROSANNE
To: ISIS PHARMACEUTICALS INC.
Reel/Frame 024763/0116 →
Assignment of Assignor's Interest
Jul 29, 2010
From: GRAHAM, MARK; TARBET, KRISTINA LEMONIDIS; DOBIS, KENNETH; CROOKE, ROSANNE
To: ISIS PHARMACEUTICALS INC.
Reel/Frame 024763/0133 →
Corrective Assignment to Correct the Conveying Party Data: the Last Name of Conveying Party Kenneth Dobis Is Incorrect. the Name Is Kenneth Dobie Previously Recorded on Reel 024763 Frame 0133. Assignor(S) Hereby Confirms the Assignment.
Aug 3, 2010
From: GRAHAM, MARK; CROOKE, ROSANNE; TARBET, KRISTINA LEMONIDIS; DOBIE, KENNETH
To: ISIS PHARMACEUTICALS INC.
Reel/Frame 024783/0658 →
Corrective Assignment to Correct the Conveying Party Data: Additional Name Listed. Rosanne M. Cooke with the Execution Date 06/07/2004. Previously Recorded on Reel 024763 Frame 0116. Assignor(S) Hereby Confirms the Assignment.
Aug 3, 2010
From: CROOKE, ROSANNE M.; GRAHAM, MARK J.
To: ISIS PHARMACEUTICALS INC.
Reel/Frame 024783/0641 →
Assignment of Assignor's Interest
May 4, 2016
From: WEDEL, MARK K.; TRIBBLE, DIANE
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 038459/0906 →
Assignment of Assignor's Interest
May 31, 2016
From: IONIS PHARMACEUTICALS, INC.
To: KASTLE THERAPEUTICS, LLC.
Reel/Frame 038754/0487 →
Assignment of Assignor's Interest
May 31, 2016
From: GENZYME CORPORATION
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 038753/0455 →